Cite
Implementation and assessment of an electronic clinical decision support tool to notify clinicians of critical hyperbilirubinemia in preterm neonates less than 35 weeks' gestation.
MLA
Xiao, Yi, et al. “Implementation and Assessment of an Electronic Clinical Decision Support Tool to Notify Clinicians of Critical Hyperbilirubinemia in Preterm Neonates Less than 35 Weeks’ Gestation.” American Journal of Clinical Pathology, vol. 161, no. 1, Jan. 2024, pp. 83–88. EBSCOhost, https://doi.org/10.1093/ajcp/aqad112.
APA
Xiao, Y., Palmucc, M., Carlin, L., Lee, C., O’Gorman, M. R. G., Nair, S., Yieh, L., & Leung, E. K.-Y. (2024). Implementation and assessment of an electronic clinical decision support tool to notify clinicians of critical hyperbilirubinemia in preterm neonates less than 35 weeks’ gestation. American Journal of Clinical Pathology, 161(1), 83–88. https://doi.org/10.1093/ajcp/aqad112
Chicago
Xiao, Yi, Mandy Palmucc, Lance Carlin, Catherine Lee, Maurice R G O’Gorman, Srikumar Nair, Leah Yieh, and Edward Ki-Yun Leung. 2024. “Implementation and Assessment of an Electronic Clinical Decision Support Tool to Notify Clinicians of Critical Hyperbilirubinemia in Preterm Neonates Less than 35 Weeks’ Gestation.” American Journal of Clinical Pathology 161 (1): 83–88. doi:10.1093/ajcp/aqad112.